Company Name : Memphis Pharmaceuticals ISIN Code : EGS38351C010 Reuters Code : MPCI.CA Content : The company sent its Disclosure Form for the BoD & the shareholders' structure for the period ended 31/03/2022, according to Article 30 of the Listing Rules. The Disclosure Form (302 KB) The Disclosure Form (302 KB)